Insights

Preterm infants born to overweight or obese mothers face higher maternal risks but show similar neonatal outcomes compared to those born to normal-weight mothers. This suggests that maternal BMI does not significantly impact infant health post-birth.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Public Health

Background:

  • Maternal overweight and obesity are significant global health concerns.
  • These conditions are associated with increased risks of obstetric complications.
  • The impact on preterm neonates requires further investigation.

Purpose of the Study:

  • To compare perinatal morbidity and mortality in preterm neonates born to overweight/obese mothers versus normal-weight mothers.
  • To identify specific neonatal outcomes affected by maternal pre-pregnancy body mass index (BMI).

Main Methods:

  • Retrospective chart review of 110 preterm infants (gestational age 28-34 weeks) born to overweight/obese mothers and 110 matched controls.
  • Data collected included maternal pre-pregnancy BMI, and maternal/neonatal complications.
  • Infants were born between 2007 and 2014 at Sheba Medical Center.

Main Results:

  • Obese mothers had higher rates of pregnancy-induced hypertension and cesarean deliveries.
  • Overweight mothers showed increased incidence of gestational diabetes.
  • No significant differences were observed in neonatal outcomes including Apgar scores, respiratory distress, cardiac issues, brain pathologies, infections, or hospitalization duration.

Conclusions:

  • Despite increased maternal complications, preterm infants born to overweight and obese mothers do not appear to be at a higher risk for neonatal complications.
  • This finding highlights the importance of maternal health management during pregnancy for preterm infant outcomes.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
334
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
363
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K